JP2007533609A - 哺乳動物におけるマグネシウム摂取の強化 - Google Patents
哺乳動物におけるマグネシウム摂取の強化 Download PDFInfo
- Publication number
- JP2007533609A JP2007533609A JP2006523924A JP2006523924A JP2007533609A JP 2007533609 A JP2007533609 A JP 2007533609A JP 2006523924 A JP2006523924 A JP 2006523924A JP 2006523924 A JP2006523924 A JP 2006523924A JP 2007533609 A JP2007533609 A JP 2007533609A
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- complex
- salt
- phospholipid
- citrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、哺乳動物におけるマグネシウム摂取の増進に関する。より詳しくは、本発明は、1つもしくはそれ以上のマグネシウム塩を、1つもしくはそれ以上の第4級アミンまたはリン脂質および1つもしくはそれ以上のジまたはトリカルボン酸と同時に投与することによる哺乳動物におけるマグネシウム摂取の増進に関する。
マグネシウムは、哺乳動物の栄養における重要なミネラルである。アデノシン三リン酸(ATP)の一部として、マグネシウムはすべての生合成過程、糖分解、環状アデノシン一リン酸(環状AMP)の形成に使用され、エネルギー代謝およびエネルギー依存膜輸送に関与し、かつリボ核酸(RNA)合成および遺伝情報の伝達に使用される。
本発明は、マグネシウム複合体および哺乳動物へのマグネシウムの投与を含む。
本発明は、マグネシウム複合体およびマグネシウムを哺乳動物に投与する方法を含む。哺乳動物にマグネシウム塩、第4級アミンまたはリン脂質、および、ジカルボン酸またはトリカルボン酸を投与することによって、被験者におけるマグネシウム摂取が改善されうることがわかった。
上室性不整脈を患う26歳の男性が、薬剤に反応せず、詳細な医療精密検査にもかかわらず、「特発性」であると判定された。
薬剤に反応しない異所性心拍を患う72歳の女性が、詳細な医療精密検査にもかかわらず、「特発性」であると判定された。
59歳の男性が、「下肢静止不能」および睡眠中の一時的下肢痙攣を患っていた。被験者がマグネシウム塩を第1週および第2週に服用した後、被験者がクエン酸コリンのみを第3週および第4週に服用し、被験者がマグネシウム塩を、クエン酸コリンの同時投与を伴って第5−第9週に服用することにより臨床的評価を行った。
以前にマグネシウム療法に反応しなかった筋過敏および線維束攣縮、良性心臓過敏および/または軽度な線維筋痛症を含むマグネシウム不足の徴候を対象に選んだ。
Claims (14)
- マグネシウム塩と、
第4級アミンまたはリン脂質と
ジカルボン酸またはトリカルボン酸と
を含むマグネシウム複合体。 - 前記複合体が水またはグリセロールをさらに含む、請求項1に記載のマグネシウム複合体。
- 前記複合体が水およびグリセロールの溶液をさらに含む、請求項1に記載のマグネシウム複合体。
- 前記マグネシウム塩が、マグネシウムグリシネート、アスコルビン酸マグネシウム、塩化マグネシウム、硫酸マグネシウム、オロチン酸マグネシウム、クエン酸マグネシウム、フマル酸マグネシウム、リンゴ酸マグネシウム、コハク酸マグネシウム、酒石酸マグネシウム、および炭酸マグネシウム、または類似のマグネシウム塩からなる群から選択される、請求項1に記載のマグネシウム複合体。
- リン脂質コリンを含む、請求項1に記載のマグネシウム複合体。
- ジカルボン酸クエン酸塩を含む、請求項1に記載のマグネシウム複合体。
- マグネシウム塩、第4級アミンまたはリン脂質、およびジカルボン酸またはトリカルボン酸の哺乳動物への投与を含む、哺乳動物におけるマグネシウム摂取を強化するための方法。
- 前記投与が経口である、請求項7に記載の方法。
- 前記マグネシウム塩、第4級アミンまたはリン脂質、およびジカルボン酸またはトリカルボン酸が水およびグリセロール溶液中に存在する、請求項7に記載の方法。
- 前記マグネシウム塩が、マグネシウムグリシネート、アスコルビン酸マグネシウム、塩化マグネシウム、硫酸マグネシウム、オロチン酸マグネシウム、クエン酸マグネシウム、フマル酸マグネシウム、リンゴ酸マグネシウム、コハク酸マグネシウム、酒石酸マグネシウム、および炭酸マグネシウム、または類似のマグネシウム塩からなる群から選択される、請求項7に記載の方法。
- リン脂質コリンを含む、請求項7に記載の方法。
- トリカルボン酸クエン酸塩を含む、請求項7に記載の方法。
- 前記哺乳動物がヒトである、請求項7に記載の方法。
- 前記マグネシウム塩、前記第4級アミンまたはリン脂質、および前記ジカルボン酸またはトリカルボン酸が同時に投与される、請求項7に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/641,291 US8017160B2 (en) | 2003-08-15 | 2003-08-15 | Enhancement of magnesium uptake in mammals |
PCT/US2004/026007 WO2005018550A2 (en) | 2003-08-15 | 2004-08-12 | Enhancement of magnesium uptake in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007533609A true JP2007533609A (ja) | 2007-11-22 |
Family
ID=34136305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006523924A Pending JP2007533609A (ja) | 2003-08-15 | 2004-08-12 | 哺乳動物におけるマグネシウム摂取の強化 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8017160B2 (ja) |
EP (2) | EP1660103B1 (ja) |
JP (1) | JP2007533609A (ja) |
CN (1) | CN1893959A (ja) |
AU (2) | AU2004266634A1 (ja) |
CA (1) | CA2535932C (ja) |
DK (1) | DK1660103T3 (ja) |
IL (1) | IL173754A (ja) |
PL (1) | PL1660103T3 (ja) |
WO (1) | WO2005018550A2 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130022673A1 (en) * | 2003-08-15 | 2013-01-24 | Russell Jaffe | Enhancement of magnesium uptake in mammals |
US8017160B2 (en) * | 2003-08-15 | 2011-09-13 | Russell Jaffe | Enhancement of magnesium uptake in mammals |
WO2014008366A2 (en) * | 2012-07-05 | 2014-01-09 | Nutramax Laboratories, Inc. | Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid |
SG11201507671SA (en) * | 2013-03-15 | 2015-10-29 | Russell Jaffe | Soft gel encapsulation |
EP4236699A1 (en) | 2020-10-28 | 2023-09-06 | Balchem Corporation | Methods of increasing magnesium bioavailability and absorption |
US11712449B1 (en) * | 2022-08-17 | 2023-08-01 | RMJH Holdings, LLC | Composition of matter, system, and method for enhanced magnesium uptake, retention, and synergistic actions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4608E (fr) * | 1905-01-25 | 1905-09-02 | Fr De L Asphalte Arme Soc | Marches d'escaliers en granit-asphalte avec rebord amovible |
US2694664A (en) * | 1951-11-19 | 1954-11-16 | American Home Prod | Choline and inositol preparation containing a surface-active agent |
US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
US5785984A (en) * | 1993-02-05 | 1998-07-28 | Kao Corporation | Taste-modifying method and bitterness-decreasing method |
WO2001084961A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3762454A (en) * | 1971-11-15 | 1973-10-02 | R Wilkins | Disposable garbage container |
US4064234A (en) * | 1974-06-04 | 1977-12-20 | Bristol-Myers Company | Methods and pharmaceutical preparation for the treatment of hypercholesterolemia |
US4355125A (en) * | 1980-11-24 | 1982-10-19 | Gulf Oil Corporation | Method for preparing stable aqueous dispersions of ionomer resins |
US4472518A (en) * | 1981-11-04 | 1984-09-18 | Mobil Oil Corporation | Shape selective reactions with zeolite catalysts modified with iron and/or cobalt |
US4540736A (en) * | 1982-05-17 | 1985-09-10 | Allied Corporation | Temporary protective coating composition of ethylene and acrylic acid and a base |
US4775719A (en) * | 1986-01-29 | 1988-10-04 | H. B. Fuller Company | Thermally stable hot melt moisture-cure polyurethane adhesive composition |
GB8620778D0 (en) * | 1986-08-28 | 1986-10-08 | Smiths Industries Ltd | Medico-surgical articles |
US5143961A (en) * | 1987-06-29 | 1992-09-01 | H. B. Fuller Licensing & Financing Inc. | Hot melt adhesive comprising water soluble polyalkyloxazoline and water insoluble polymer |
NZ242597A (en) * | 1991-05-14 | 1995-07-26 | Grace W R & Co | Co-extruded water soluble laminated polymeric film and methods of extruding it |
EP0513692A1 (en) * | 1991-05-17 | 1992-11-19 | Air Products And Chemicals, Inc. | Water soluble multilayer film for packaging alkaline materials |
US5292794A (en) * | 1991-07-01 | 1994-03-08 | Alliedsignal Inc. | Removable protective coating composition for spray painting areas |
US5217795A (en) * | 1991-08-13 | 1993-06-08 | Kimberly-Clark Corporation | Polymeric web compositions having improved alkaline solubility for use as fibers |
GB9225071D0 (en) * | 1992-12-01 | 1993-01-20 | Welland Medical Ltd | Ostomy bags |
US5424265A (en) * | 1993-06-15 | 1995-06-13 | Safetec Of America | Capsule for absorbing liquid waste in a suction canister |
GB2290712B (en) * | 1994-07-01 | 1998-03-25 | Welland Medical Ltd | Ostomy bag filters |
US5472518A (en) * | 1994-12-30 | 1995-12-05 | Minnesota Mining And Manufacturing Company | Method of disposal for dispersible compositions and articles |
US5849337A (en) | 1997-06-27 | 1998-12-15 | Gusty Winds Corporation | Method of enhancing magnesium absorption and prevention of atherosclerosis |
US8017160B2 (en) * | 2003-08-15 | 2011-09-13 | Russell Jaffe | Enhancement of magnesium uptake in mammals |
-
2003
- 2003-08-15 US US10/641,291 patent/US8017160B2/en not_active Expired - Lifetime
-
2004
- 2004-08-12 PL PL04780786T patent/PL1660103T3/pl unknown
- 2004-08-12 EP EP04780786.2A patent/EP1660103B1/en active Active
- 2004-08-12 CN CNA2004800294599A patent/CN1893959A/zh active Pending
- 2004-08-12 WO PCT/US2004/026007 patent/WO2005018550A2/en active Application Filing
- 2004-08-12 DK DK04780786.2T patent/DK1660103T3/da active
- 2004-08-12 EP EP13151531.4A patent/EP2606900A1/en not_active Withdrawn
- 2004-08-12 CA CA2535932A patent/CA2535932C/en active Active
- 2004-08-12 JP JP2006523924A patent/JP2007533609A/ja active Pending
- 2004-08-12 AU AU2004266634A patent/AU2004266634A1/en not_active Abandoned
-
2006
- 2006-02-15 IL IL173754A patent/IL173754A/en active IP Right Grant
-
2011
- 2011-03-11 AU AU2011201073A patent/AU2011201073B2/en not_active Ceased
- 2011-04-08 US US13/082,939 patent/US20110183034A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4608E (fr) * | 1905-01-25 | 1905-09-02 | Fr De L Asphalte Arme Soc | Marches d'escaliers en granit-asphalte avec rebord amovible |
US2694664A (en) * | 1951-11-19 | 1954-11-16 | American Home Prod | Choline and inositol preparation containing a surface-active agent |
US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
US5785984A (en) * | 1993-02-05 | 1998-07-28 | Kao Corporation | Taste-modifying method and bitterness-decreasing method |
WO2001084961A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
Also Published As
Publication number | Publication date |
---|---|
CA2535932A1 (en) | 2005-03-03 |
DK1660103T3 (da) | 2019-05-06 |
EP1660103A4 (en) | 2009-07-08 |
CN1893959A (zh) | 2007-01-10 |
AU2004266634A1 (en) | 2005-03-03 |
US20050037998A1 (en) | 2005-02-17 |
AU2011201073B2 (en) | 2012-01-19 |
EP1660103A2 (en) | 2006-05-31 |
IL173754A0 (en) | 2006-07-05 |
WO2005018550A3 (en) | 2005-10-06 |
EP2606900A1 (en) | 2013-06-26 |
US20110183034A1 (en) | 2011-07-28 |
US8017160B2 (en) | 2011-09-13 |
PL1660103T3 (pl) | 2019-07-31 |
WO2005018550A2 (en) | 2005-03-03 |
IL173754A (en) | 2015-05-31 |
WO2005018550B1 (en) | 2005-12-15 |
AU2011201073A1 (en) | 2011-03-31 |
EP1660103B1 (en) | 2018-12-26 |
CA2535932C (en) | 2012-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2891126T3 (es) | Actividades de apoyo de la vida diaria | |
US20050196434A1 (en) | Pharmaceutical composition and method for the transdermal delivery of magnesium | |
US20030190369A1 (en) | Vitamin formulation for enhancing bone strength | |
AU2011201073B2 (en) | Enhancement of magnesium uptake in mammals | |
US20030119888A1 (en) | Composition comprising l-arginine as a muscle growth stimulant and use thereof | |
JP2738541B2 (ja) | 骨粗鬆症および関連障害の治療法 | |
JP3622985B2 (ja) | マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法 | |
RU2372899C2 (ru) | Фармацевтическая композиция для лечения псориаза, содержащая l-серин, l-изолейцин, фолиевую кислоту и микроэлементы | |
US11596166B2 (en) | Compositions and methods for treating aging and/or improving human health | |
US20130022673A1 (en) | Enhancement of magnesium uptake in mammals | |
AU651824B2 (en) | Pharmaceutical composition | |
US11458150B2 (en) | Methylphosphinic acid compositions and methods for reducing aging | |
JPH0563452B2 (ja) | ||
MXPA06001818A (en) | Enhancement of magnesium uptake in mammals | |
US20050196433A1 (en) | Pharmaceutical composition and method for the transdermal delivery of magnesium | |
US20050043287A1 (en) | Composition comprising L-arginine as a muscle growth stimulant and use thereof | |
JPH0235057A (ja) | 機能性食品 | |
UA108993U (uk) | Суміш суха для ентерального харчування хворих в критичних станах |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070813 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20090507 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110228 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110307 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110328 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110404 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110427 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110510 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110905 |